In hepatocellular carcinoma and glioblastoma, the role of METTL3 is unclear due to conflicting findings about whether the m6A methyltransferase complex promotes or inhibits cancer pathogenesis.8,41,42. Here, METTL3 is linked to hepatocellular carcinoma.